Urology refers to the branch of medicine that focuses on surgical and medical diseases related to the urinary tract. It involves diagnosis, evaluation, and treatment of diseases in ureters, bladder, kidneys, and testicles.
Bladder cancer is the rapid, uncontrolled growth of abnormal cells in the urinary bladder lining with epithelial cells. These cancerous cells may even spread through the lining into the muscular wall of the bladder.
Release coatings are silicone-based chemicals applied in the form of coatings to paper and plastic substances. These release coatings perform the function of a release agent, allowing adhesive to release earlier.
Spray drying equipment is utilized to remove the moisture content from the product. A basic spray drying operation consists of a liquid/slurry being dispersed in the form of small droplets and then brought in contact with a hot gas.
Activated carbon fibers (ACFs) possess superior properties of carbon fiber and activated carbon. These are a modified form of carbon materials with well-defined porous structure, high surface area, and higher absorption capacity.
Healthcare payer solution is a strategic systematic plan that offers a broad range of innovative and cost-effective healthcare solutions to improve operational efficiency and to reach the ultimate goal of health care transformations.
Advanced and ultra-high-strength steel are complex sophisticated materials containing multiphase microstructures and chemical compositions resulting from precisely controlled cooling and heating processes.
Flooring of aircrafts is extensively covered by honeycomb sandwich panels. Commercial aircraft flooring is about 1cm thick and is made of glass or carbon fiber reinforced epoxy skins with a Nomex honeycomb core.
A hydrolyzed salt of moxifloxacin and a fourth-generation antibiotic, Moxifloxacin HCl is used as broad-spectrum antibiotic, which is active against both gram-negative and gram-positive strains of bacteria.
The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020. The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020.